PVLA
Price
$50.10
Change
-$3.32 (-6.21%)
Updated
Aug 25, 04:59 PM (EDT)
Capitalization
554.42M
RGNX
Price
$8.97
Change
-$0.04 (-0.44%)
Updated
Aug 25, 04:59 PM (EDT)
Capitalization
455.13M
72 days until earnings call
Interact to see
Advertisement

PVLA vs RGNX

Header iconPVLA vs RGNX Comparison
Open Charts PVLA vs RGNXBanner chart's image
Palvella Therapeutics
Price$50.10
Change-$3.32 (-6.21%)
Volume$2.1K
Capitalization554.42M
REGENXBIO
Price$8.97
Change-$0.04 (-0.44%)
Volume$15.06K
Capitalization455.13M
PVLA vs RGNX Comparison Chart in %
Loading...
PVLA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RGNX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
PVLA vs. RGNX commentary
Aug 26, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PVLA is a Hold and RGNX is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 26, 2025
Stock price -- (PVLA: $53.42 vs. RGNX: $8.97)
Brand notoriety: PVLA and RGNX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: PVLA: 99% vs. RGNX: 119%
Market capitalization -- PVLA: $554.42M vs. RGNX: $455.13M
PVLA [@Biotechnology] is valued at $554.42M. RGNX’s [@Biotechnology] market capitalization is $455.13M. The market cap for tickers in the [@Biotechnology] industry ranges from $99.72B to $0. The average market capitalization across the [@Biotechnology] industry is $1.86B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

PVLA’s FA Score shows that 1 FA rating(s) are green whileRGNX’s FA Score has 1 green FA rating(s).

  • PVLA’s FA Score: 1 green, 4 red.
  • RGNX’s FA Score: 1 green, 4 red.
According to our system of comparison, PVLA is a better buy in the long-term than RGNX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

PVLA’s TA Score shows that 3 TA indicator(s) are bullish while RGNX’s TA Score has 7 bullish TA indicator(s).

  • PVLA’s TA Score: 3 bullish, 4 bearish.
  • RGNX’s TA Score: 7 bullish, 2 bearish.
According to our system of comparison, RGNX is a better buy in the short-term than PVLA.

Price Growth

PVLA (@Biotechnology) experienced а +12.94% price change this week, while RGNX (@Biotechnology) price change was +2.99% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.14%. For the same industry, the average monthly price growth was +18.77%, and the average quarterly price growth was +29.32%.

Reported Earning Dates

RGNX is expected to report earnings on Nov 05, 2025.

Industries' Descriptions

@Biotechnology (+2.14% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
PVLA($554M) has a higher market cap than RGNX($455M). PVLA YTD gains are higher at: 345.167 vs. RGNX (16.041). PVLA has higher annual earnings (EBITDA): -23.27M vs. RGNX (-129.93M). RGNX has more cash in the bank: 323M vs. PVLA (70.4M). RGNX has higher revenues than PVLA: RGNX (156M) vs PVLA (0).
PVLARGNXPVLA / RGNX
Capitalization554M455M122%
EBITDA-23.27M-129.93M18%
Gain YTD345.16716.0412,152%
P/E Ratio14.22N/A-
Revenue0156M-
Total Cash70.4M323M22%
Total DebtN/A77.7M-
FUNDAMENTALS RATINGS
PVLA vs RGNX: Fundamental Ratings
PVLA
RGNX
OUTLOOK RATING
1..100
3869
VALUATION
overvalued / fair valued / undervalued
1..100
70
Overvalued
71
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9798
PRICE GROWTH RATING
1..100
3559
P/E GROWTH RATING
1..100
1223
SEASONALITY SCORE
1..100
5013

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

PVLA's Valuation (70) in the null industry is in the same range as RGNX (71) in the Biotechnology industry. This means that PVLA’s stock grew similarly to RGNX’s over the last 12 months.

PVLA's Profit vs Risk Rating (100) in the null industry is in the same range as RGNX (100) in the Biotechnology industry. This means that PVLA’s stock grew similarly to RGNX’s over the last 12 months.

PVLA's SMR Rating (97) in the null industry is in the same range as RGNX (98) in the Biotechnology industry. This means that PVLA’s stock grew similarly to RGNX’s over the last 12 months.

PVLA's Price Growth Rating (35) in the null industry is in the same range as RGNX (59) in the Biotechnology industry. This means that PVLA’s stock grew similarly to RGNX’s over the last 12 months.

PVLA's P/E Growth Rating (12) in the null industry is in the same range as RGNX (23) in the Biotechnology industry. This means that PVLA’s stock grew similarly to RGNX’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
PVLARGNX
RSI
ODDS (%)
Bearish Trend 4 days ago
90%
Bullish Trend 4 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 4 days ago
84%
Bearish Trend 4 days ago
85%
Momentum
ODDS (%)
N/A
Bullish Trend 4 days ago
83%
MACD
ODDS (%)
Bullish Trend 4 days ago
81%
Bullish Trend 4 days ago
68%
TrendWeek
ODDS (%)
Bullish Trend 4 days ago
83%
Bullish Trend 4 days ago
77%
TrendMonth
ODDS (%)
Bullish Trend 4 days ago
80%
Bearish Trend 4 days ago
86%
Advances
ODDS (%)
Bullish Trend 4 days ago
85%
Bullish Trend 4 days ago
77%
Declines
ODDS (%)
Bearish Trend 25 days ago
85%
Bearish Trend 8 days ago
84%
BollingerBands
ODDS (%)
Bearish Trend 4 days ago
90%
Bullish Trend 4 days ago
89%
Aroon
ODDS (%)
Bullish Trend 4 days ago
81%
Bullish Trend 4 days ago
65%
View a ticker or compare two or three
Interact to see
Advertisement
PVLA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RGNX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
IRGIX10.40N/A
N/A
VY® CBRE Global Real Estate I
AQEAX15.88N/A
N/A
Columbia Disciplined Core A
RYREX41.94N/A
N/A
Rydex Real Estate A
TEGIX45.38N/A
N/A
Touchstone Mid Cap Growth Inst
FGIWX13.11N/A
N/A
Nuveen Global Infrastructure R6

PVLA and

Correlation & Price change

A.I.dvisor indicates that over the last year, PVLA has been loosely correlated with DRMA. These tickers have moved in lockstep 42% of the time. This A.I.-generated data suggests there is some statistical probability that if PVLA jumps, then DRMA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PVLA
1D Price
Change %
PVLA100%
+4.11%
DRMA - PVLA
42%
Loosely correlated
+2.81%
OCUL - PVLA
34%
Loosely correlated
+1.40%
RGNX - PVLA
33%
Poorly correlated
+11.10%
FOLD - PVLA
32%
Poorly correlated
+0.13%
ERAS - PVLA
32%
Poorly correlated
+6.67%
More